<?xml version="1.0" encoding="UTF-8"?>
<ref id="B3">
 <label>3.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Baud’huin</surname>
    <given-names>M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lamoureux</surname>
    <given-names>F.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Duplomb</surname>
    <given-names>L.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Redini</surname>
    <given-names>F.</given-names>
   </name> and 
   <name name-style="western">
    <surname>Heymann</surname>
    <given-names>D.</given-names>
   </name>
  </person-group> (
  <year>2007</year>) 
  <article-title>RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases</article-title>. 
  <source>Cell. Mol. Life Sci.</source>
  <volume>64</volume>, 
  <fpage>2334</fpage>–
  <lpage>2350</lpage>
  <pub-id pub-id-type="doi">10.1007/s00018-007-7104-0</pub-id>
  <?supplied-pmid 17530461?>
  <pub-id pub-id-type="pmid">17530461</pub-id>
 </mixed-citation>
</ref>
